Prognostic significance of oxygen saturation/fraction of inspired oxygen 3 days after initiation of tocilizumab treatment in patients with COVID-19
The SpO<sub>2</sub>/FiO<sub>2</sub> on day 3 post-tocilizumab initiation was a predictor of COVID-19 prognosis, which could be employed in determining clinical decisions. Prompt alternative interventions should be considered when this ratio does not improve.
Authors
- Hisato Hiranuma
- Yutaka Kozu (ORCID: https://orcid.org/0000-0003-4472-3625)
- Yasunori Itoda
- Shun Yokota
- Kazuo Chin (ORCID: https://orcid.org/0000-0002-1011-7478)
- Mamiko Hoshi
- Kenji Mizumura (ORCID: https://orcid.org/0000-0001-8532-9670)
- Yusuke Jinno
- Tetsuo Shimizu (ORCID: https://orcid.org/0000-0003-3405-9652)
- Yasuhiro Gon
- Yusuke Kurosawa
- K. Soda (ORCID: https://orcid.org/0009-0009-1655-2022)
- Tadateru Takayama (ORCID: https://orcid.org/0000-0003-2939-5854)
- Tsukasa Nishizawa
Institutions
- Nihon University (JP)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1016/j.resinv.2024.10.005
- Primary Topic
- Hematological disorders and diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00